{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:33:14Z","timestamp":1790771594678,"version":"4.1.0"},"reference-count":94,"publisher":"American Association for Cancer Research (AACR)","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Ductal carcinoma in situ (DCIS) is the most common type (80%) of noninvasive breast lesions in women. The lack of validated prognostic markers, limited patient numbers, and variable tissue quality have a significant impact on the diagnosis, risk stratification, patient enrollment, and results of clinical studies. In this study, we performed label-free quantitative proteomics on 50 clinical formalin-fixed, paraffin-embedded biopsies, validating 22 putative biomarkers from independent genetic studies. Our comprehensive proteomic phenotyping reveals more than 380 differentially expressed proteins and metabolic vulnerabilities, which can inform new therapeutic strategies for DCIS and invasive ductal carcinoma. Due to the readily druggable nature of proteins and metabolic enzymes or metabolism inhibitors, this study is of high interest for clinical research and the pharmaceutical industry. To further evaluate our findings, and to promote the clinical translation of our study, we developed a highly multiplexed targeted proteomics assay for 90 proteins associated with cancer metabolism, RNA regulation, and signature cancer pathways, such as PI3K\/AKT\/mTOR and EGFR\/RAS\/RAF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study provides real-world evidence for DCIS, a disease for which currently no molecular tools or biomarkers exist, and gives an unbiased, comprehensive, and deep proteomic profile, identifying &amp;gt;380 actionable targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0287","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T07:16:56Z","timestamp":1735197416000},"page":"138-149","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Proteomics Reveals Vulnerabilities in Noninvasive Breast Ductal Carcinoma and Drives Personalized Treatment Strategies"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8453-6664","authenticated-orcid":false,"given":"Georgia","family":"Mitsa","sequence":"first","affiliation":[{"name":"1Division of Experimental Medicine, McGill University, Montr\u00e9al, Canada."},{"name":"2Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Montr\u00e9al, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0616-9379","authenticated-orcid":false,"given":"Livia","family":"Florianova","sequence":"additional","affiliation":[{"name":"3Department of Pathology, McGill University, Montr\u00e9al, Canada."},{"name":"4Division of Pathology, Jewish General Hospital, Montr\u00e9al, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1885-8703","authenticated-orcid":false,"given":"Josiane","family":"Lafleur","sequence":"additional","affiliation":[{"name":"5Segal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montr\u00e9al, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1015-4383","authenticated-orcid":false,"given":"Adriana","family":"Aguilar-Mahecha","sequence":"additional","affiliation":[{"name":"5Segal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montr\u00e9al, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4960-5460","authenticated-orcid":false,"given":"Rene P.","family":"Zahedi","sequence":"additional","affiliation":[{"name":"6Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada."},{"name":"7Department of Internal Medicine, University of Manitoba, Winnipeg, Canada."},{"name":"8Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Canada."},{"name":"9CancerCare Manitoba Research Institute, Winnipeg, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6350-0227","authenticated-orcid":false,"given":"Sonia V.","family":"del Rincon","sequence":"additional","affiliation":[{"name":"1Division of Experimental Medicine, McGill University, Montr\u00e9al, Canada."},{"name":"5Segal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montr\u00e9al, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2633-5410","authenticated-orcid":false,"given":"Mark","family":"Basik","sequence":"additional","affiliation":[{"name":"1Division of Experimental Medicine, McGill University, Montr\u00e9al, Canada."},{"name":"10Department of Medicine, McGill University, Montr\u00e9al, Canada."},{"name":"11Gerald Bronfman Department of Oncology, McGill University, Montr\u00e9al, Canada."},{"name":"12Department of Surgery, McGill University, Montr\u00e9al, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2394-6512","authenticated-orcid":false,"given":"Christoph H.","family":"Borchers","sequence":"additional","affiliation":[{"name":"1Division of Experimental Medicine, McGill University, Montr\u00e9al, Canada."},{"name":"2Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Montr\u00e9al, Canada."},{"name":"3Department of Pathology, McGill University, Montr\u00e9al, Canada."},{"name":"5Segal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montr\u00e9al, Canada."},{"name":"11Gerald Bronfman Department of Oncology, McGill University, Montr\u00e9al, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5430-3750","authenticated-orcid":false,"given":"Gerald","family":"Batist","sequence":"additional","affiliation":[{"name":"1Division of Experimental Medicine, McGill University, Montr\u00e9al, Canada."},{"name":"5Segal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montr\u00e9al, Canada."},{"name":"12Department of Surgery, McGill University, Montr\u00e9al, Canada."},{"name":"13Exactis Innovation, Montr\u00e9al, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"2025051308483226100_bib1","doi-asserted-by":"crossref","first-page":"m1570","DOI":"10.1136\/bmj.m1570","article-title":"Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988\u20132014: population based observational cohort study","volume":"369","author":"Mannu","year":"2020","journal-title":"BMJ"},{"key":"2025051308483226100_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/bcr1346","article-title":"Overdiagnosis and overtreatment of breast cancer: rates of ductal carcinoma in situ: a US perspective","volume":"7","author":"Kumar","year":"2005","journal-title":"Breast Cancer Res"},{"key":"2025051308483226100_bib3","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up","volume":"103","author":"Sanders","year":"2005","journal-title":"Cancer"},{"key":"2025051308483226100_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/bcr1397","article-title":"Overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective","volume":"8","author":"Jones","year":"2006","journal-title":"Breast Cancer Res"},{"key":"2025051308483226100_bib5","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/cncr.20979","article-title":"Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses\u2019 Health Study","volume":"103","author":"Collins","year":"2005","journal-title":"Cancer"},{"key":"2025051308483226100_bib6","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s41416-022-01885-5","article-title":"Is loss of p53 a driver of ductal carcinoma in situ progression?","volume":"127","author":"Morrissey","year":"2022","journal-title":"Br J Cancer"},{"key":"2025051308483226100_bib7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0046-8177(98)90196-4","article-title":"Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up","volume":"29","author":"Badve","year":"1998","journal-title":"Hum Pathol"},{"key":"2025051308483226100_bib8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/PAP.0000000000000074","article-title":"Tumor heterogeneity in breast cancer","volume":"22","author":"Badve","year":"2015","journal-title":"Adv Anat Pathol"},{"key":"2025051308483226100_bib9","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s41416-020-01216-6","article-title":"Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast","volume":"124","author":"Badve","year":"2021","journal-title":"Br J Cancer"},{"key":"2025051308483226100_bib10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/modpathol.2017.143","article-title":"Single-cell heterogeneity in ductal carcinoma in situ of breast","volume":"31","author":"Gerdes","year":"2018","journal-title":"Mod Pathol"},{"key":"2025051308483226100_bib11","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.3390\/ijms23084443","article-title":"A non-hazardous deparaffinization protocol enables quantitative proteomics of core needle biopsy-sized formalin-fixed and paraffin-embedded (FFPE) tissue specimens","volume":"23","author":"Mitsa","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025051308483226100_bib12","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s10337-019-03769-y","article-title":"Paraffin-embedded tissue as a novel matrix in metabolomics study: optimization of metabolite extraction method","volume":"82","author":"Buszewska-Forajta","year":"2019","journal-title":"Chromatographia"},{"key":"2025051308483226100_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.12775","article-title":"Innovation in metabolomics to improve personalized healthcare","volume":"1346","author":"Cacciatore","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"2025051308483226100_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1158\/1541-7786.MCR-16-0262","article-title":"Metabolic profiling in formalin-fixed and paraffin-embedded prostate cancer tissues","volume":"15","author":"Cacciatore","year":"2017","journal-title":"Mol Cancer Res"},{"key":"2025051308483226100_bib15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/ph15111307","article-title":"Evaluation of formalin-fixed and FFPE tissues for spatially resolved metabolomics and drug distribution studies","volume":"15","author":"Dannhorn","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"2025051308483226100_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.aca.2020.08.005","article-title":"Optimized protocol for metabolomic and lipidomic profiling in formalin-fixed paraffin-embedded kidney tissue by LC-MS","volume":"1134","author":"Neef","year":"2020","journal-title":"Anal Chim Acta"},{"key":"2025051308483226100_bib17","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/jcbfm.2015.70","article-title":"Physiology-based kinetic modeling of neuronal energy metabolism unravels the molecular basis of NAD(P)H fluorescence transients","volume":"35","author":"Berndt","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"2025051308483226100_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nbt.2839","article-title":"ProteomeXchange provides globally coordinated proteomics data submission and dissemination","volume":"32","author":"Vizca\u00edno","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2025051308483226100_bib19","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"2025051308483226100_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"2025051308483226100_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"2025051308483226100_bib22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"2025051308483226100_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41523-021-00365-y","article-title":"The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ","volume":"8","author":"Nachmanson","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"2025051308483226100_bib24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s42003-021-01959-9","article-title":"Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast","volume":"4","author":"Nagasawa","year":"2021","journal-title":"Commun Biol"},{"key":"2025051308483226100_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ymeth.2006.07.028","article-title":"Analyzing chromatin remodeling complexes using shotgun proteomics and normalized spectral abundance factors","volume":"40","author":"Florens","year":"2006","journal-title":"Methods"},{"key":"2025051308483226100_bib26","doi-asserted-by":"crossref","first-page":"867938","DOI":"10.3389\/frans.2022.867938","article-title":"Review of variable selection methods for discriminant-type problems in chemometrics","volume":"2","author":"Sorochan Armstrong","year":"2022","journal-title":"Front Anal Sci"},{"key":"2025051308483226100_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-021-03227-0","article-title":"Pan-cancer quantitation of epithelial-mesenchymal transition dynamics using parallel reaction monitoring-based targeted proteomics approach","volume":"20","author":"Jain","year":"2022","journal-title":"J Transl Med"},{"key":"2025051308483226100_bib28","doi-asserted-by":"crossref","first-page":"9836256","DOI":"10.1155\/2018\/9836256","article-title":"Onco-multi-OMICS approach: a new frontier in cancer research","volume":"2018","author":"Chakraborty","year":"2018","journal-title":"Biomed Res Int"},{"key":"2025051308483226100_bib29","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.3390\/cancers12113270","article-title":"Integration and comparison of transcriptomic and proteomic data for meningioma","volume":"12","author":"Dunn","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2025051308483226100_bib30","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s42255-021-00504-6","article-title":"Spatial discordances between mRNAs and proteins in the intestinal epithelium","volume":"3","author":"Harnik","year":"2021","journal-title":"Nat Metab"},{"key":"2025051308483226100_bib31","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1038\/s41467-022-30573-4","article-title":"Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma","volume":"13","author":"Rebbeck","year":"2022","journal-title":"Nat Commun"},{"key":"2025051308483226100_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12885-020-6608-y","article-title":"Potential biomarkers of ductal carcinoma in situ progression","volume":"20","author":"Dettogni","year":"2020","journal-title":"BMC Cancer"},{"key":"2025051308483226100_bib33","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/onc.2012.62","article-title":"FOXA1 represses the molecular phenotype of basal breast cancer cells","volume":"32","author":"Bernardo","year":"2013","journal-title":"Oncogene"},{"key":"2025051308483226100_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BSR20110046","article-title":"FOXA1: a transcription factor with parallel functions in development and cancer","volume":"32","author":"Bernardo","year":"2012","journal-title":"Biosci Rep"},{"key":"2025051308483226100_bib35","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.3390\/cancers13205205","article-title":"FOXA1: a pioneer of nuclear receptor action in breast cancer","volume":"13","author":"Seachrist","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025051308483226100_bib36","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.onc.1209170","article-title":"BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1)","volume":"25","author":"Williamson","year":"2006","journal-title":"Oncogene"},{"key":"2025051308483226100_bib37","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/ijc.22389","article-title":"FOXA1: growth inhibitor and a favorable prognostic factor in human breast cancer","volume":"120","author":"Wolf","year":"2007","journal-title":"Int J Cancer"},{"key":"2025051308483226100_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1158\/0008-5472.CAN-21-0614","article-title":"BRAF inhibitors reprogram cancer-associated fibroblasts to drive matrix remodeling and therapeutic escape in melanoma","volume":"82","author":"Liu","year":"2022","journal-title":"Cancer Res"},{"key":"2025051308483226100_bib39","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-07-6151","article-title":"Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer","volume":"68","author":"Barnett","year":"2008","journal-title":"Cancer Res"},{"key":"2025051308483226100_bib40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4149\/neo_2018_180819N624","article-title":"High expression of carbonic anhydrase 12 (CA12) is associated with good prognosis in breast cancer","volume":"66","author":"Li","year":"2019","journal-title":"Neoplasma"},{"key":"2025051308483226100_bib41","doi-asserted-by":"crossref","first-page":"e153110","DOI":"10.1172\/JCI153110","article-title":"Carbonic anhydrase XII mediates the survival and prometastatic functions of macrophages in human hepatocellular carcinoma","volume":"132","author":"Ning","year":"2022","journal-title":"J Clin Invest"},{"key":"2025051308483226100_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/1078-0432.CCR-09-1630","article-title":"Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer","volume":"16","author":"Charafe-Jauffret","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2025051308483226100_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/scd.2008.0055","article-title":"ALDH1 as a functional marker of cancer stem and progenitor cells","volume":"18","author":"Douville","year":"2009","journal-title":"Stem Cells Dev"},{"key":"2025051308483226100_bib44","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41598-020-80336-8","article-title":"Transcript levels of keratin 1\/5\/6\/14\/15\/16\/17 as potential prognostic indicators in melanoma patients","volume":"11","author":"Han","year":"2021","journal-title":"Sci Rep"},{"key":"2025051308483226100_bib45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/onc.2016.221","article-title":"KRT19 directly interacts with beta-catenin\/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties","volume":"36","author":"Saha","year":"2017","journal-title":"Oncogene"},{"key":"2025051308483226100_bib46","doi-asserted-by":"crossref","first-page":"112019","DOI":"10.3390\/cancers11010099","article-title":"Opposing regulation of cancer properties via KRT19-mediated differential modulation of Wnt\/\u03b2-catenin\/notch signaling in breast and colon cancers","volume":"11","author":"Saha","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2025051308483226100_bib47","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.18632\/oncotarget.27778","article-title":"Heterogeneity of CEACAM5 in breast cancer","volume":"11","author":"Bechmann","year":"2020","journal-title":"Oncotarget"},{"key":"2025051308483226100_bib48","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/abbs\/gmv075","article-title":"Down-regulation of CEACAM1 in breast cancer","volume":"47","author":"Yang","year":"2015","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2025051308483226100_bib49","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1158\/1078-0432.CCR-21-1239","article-title":"Prognostic and predictive value of HER2 expression in ductal carcinoma in situ: results from the UK\/ANZ DCIS randomized trial","volume":"27","author":"Thorat","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2025051308483226100_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13058-024-01875-w","article-title":"Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance","volume":"26","author":"Van Bockstal","year":"2024","journal-title":"Breast Cancer Res"},{"key":"2025051308483226100_bib51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41392-024-01779-3","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2025051308483226100_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12032-022-01876-9","article-title":"The clinical significance of HER2 expression in DCIS","volume":"40","author":"Akrida","year":"2022","journal-title":"Med Oncol"},{"key":"2025051308483226100_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/379091a0","article-title":"Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase","volume":"379","author":"Hannigan","year":"1996","journal-title":"Nature"},{"key":"2025051308483226100_bib54","doi-asserted-by":"crossref","first-page":"11211","DOI":"10.1073\/pnas.95.19.11211","article-title":"Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B\/AKT by the integrin-linked kinase","volume":"95","author":"Delcommenne","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025051308483226100_bib55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-1-61779-166-6_17","article-title":"Overview of integrin signaling in the immune system","volume":"757","author":"Kinashi","year":"2012","journal-title":"Methods Mol Biol"},{"key":"2025051308483226100_bib56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.21037\/jgo-22-92","article-title":"The early predictive effect of low expression of the ITGA4 in colorectal cancer","volume":"13","author":"Mo","year":"2022","journal-title":"J Gastrointest Oncol"},{"key":"2025051308483226100_bib57","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1111\/jcmm.13502","article-title":"Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumours","volume":"22","author":"Pulkka","year":"2018","journal-title":"J Cell Mol Med"},{"key":"2025051308483226100_bib58","doi-asserted-by":"crossref","first-page":"765","DOI":"10.18632\/oncoscience.104","article-title":"The emerging roles of GPRC5A in diseases","volume":"1","author":"Zhou","year":"2014","journal-title":"Oncoscience"},{"key":"2025051308483226100_bib59","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.7150\/jca.52578","article-title":"GPRC5A: an emerging prognostic biomarker for predicting malignancy of Pancreatic Cancer based on bioinformatics analysis","volume":"12","author":"Qian","year":"2021","journal-title":"J Cancer"},{"key":"2025051308483226100_bib60","doi-asserted-by":"crossref","first-page":"624493","DOI":"10.3389\/fonc.2020.624493","article-title":"GPRC5A is a negative regulator of the pro-survival PI3K\/akt signaling pathway in triple-negative breast cancer","volume":"10","author":"Yang","year":"2020","journal-title":"Front Oncol"},{"key":"2025051308483226100_bib61","doi-asserted-by":"crossref","first-page":"e48467","DOI":"10.15252\/embr.201948467","article-title":"Androgen receptor-regulated circ FNTA activates KRAS signaling to promote bladder cancer invasion","volume":"21","author":"Chen","year":"2020","journal-title":"EMBO Rep"},{"key":"2025051308483226100_bib62","first-page":"1017","article-title":"circ-FNTA accelerates proliferation and invasion of bladder cancer","volume":"19","author":"Tian","year":"2020","journal-title":"Oncol Lett"},{"key":"2025051308483226100_bib63","first-page":"F51","article-title":"Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?","volume":"1333","author":"Cox","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"2025051308483226100_bib64","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/bcr947","article-title":"New targets for therapy in breast cancer: farnesyltransferase inhibitors","volume":"6","author":"Head","year":"2004","journal-title":"Breast Cancer Res"},{"key":"2025051308483226100_bib65","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1200\/JCO.1999.17.11.3631","article-title":"Ras protein farnesyltransferase: a strategic target for anticancer therapeutic development","volume":"17","author":"Rowinsky","year":"1999","journal-title":"J Clin Oncol"},{"key":"2025051308483226100_bib66","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1038\/sj.onc.1204146","article-title":"Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies","volume":"19","author":"Sebti","year":"2000","journal-title":"Oncogene"},{"key":"2025051308483226100_bib67","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/s41591-018-0230-4","article-title":"Cancer cells exploit an orphan RNA to drive metastatic progression","volume":"24","author":"Fish","year":"2018","journal-title":"Nat Med"},{"key":"2025051308483226100_bib68","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.gendis.2019.09.009","article-title":"RISC assembly and post-transcriptional gene regulation in Hepatocellular Carcinoma","volume":"7","author":"Santhekadur","year":"2020","journal-title":"Genes Dis"},{"key":"2025051308483226100_bib69","doi-asserted-by":"crossref","first-page":"e0172854","DOI":"10.1371\/journal.pone.0172854","article-title":"Mice, double deficient in lysosomal serine carboxypeptidases Scpep1 and Cathepsin A develop the hyperproliferative vesicular corneal dystrophy and hypertrophic skin thickenings","volume":"12","author":"Pan","year":"2017","journal-title":"PLoS One"},{"key":"2025051308483226100_bib70","doi-asserted-by":"crossref","first-page":"8092751","DOI":"10.1155\/2022\/8092751","article-title":"HDAC10 inhibits cervical cancer progression through downregulating the HDAC10-microRNA-223-EPB41L3 axis","volume":"2022","author":"Gu","year":"2022","journal-title":"J Oncol"},{"key":"2025051308483226100_bib71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-4598-5-4","article-title":"The tumor suppressor DAL-1\/4.1B and protein methylation cooperate in inducing apoptosis in MCF-7 breast cancer cells","volume":"5","author":"Jiang","year":"2006","journal-title":"Mol Cancer"},{"key":"2025051308483226100_bib72","first-page":"283","article-title":"Over-expression of EPB41L3 promotes apoptosis of human cervical carcinoma cells through PI3K\/AKT signaling","volume":"69","author":"Tuerxun","year":"2022","journal-title":"Acta Biochim Pol"},{"key":"2025051308483226100_bib73","first-page":"1443","article-title":"EPB41L3 is a potential tumor suppressor gene and prognostic indicator in esophageal squamous cell carcinoma","volume":"52","author":"Zeng","year":"2018","journal-title":"Int J Oncol"},{"key":"2025051308483226100_bib74","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/s41467-021-22389-5","article-title":"ATP6V0A1 encoding the a1-subunit of the V0 domain of vacuolar H+-ATPases is essential for brain development in humans and mice","volume":"12","author":"Aoto","year":"2021","journal-title":"Nat Commun"},{"key":"2025051308483226100_bib75","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tibs.2015.08.005","article-title":"Recent insights into the structure, regulation, and function of the V-ATPases","volume":"40","author":"Cotter","year":"2015","journal-title":"Trends Biochem Sci"},{"key":"2025051308483226100_bib76","doi-asserted-by":"crossref","first-page":"32731","DOI":"10.1074\/jbc.M113.503771","article-title":"The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells","volume":"288","author":"Capecci","year":"2013","journal-title":"J Biol Chem"},{"key":"2025051308483226100_bib77","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1016\/j.csbj.2022.08.026","article-title":"Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma","volume":"20","author":"Wang","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"2025051308483226100_bib78","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.3390\/cancers14235951","article-title":"ACAP1 deficiency predicts inferior immunotherapy response in solid tumors","volume":"14","author":"Yi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025051308483226100_bib79","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1089\/dna.2020.5596","article-title":"Expression of ACAP1 is associated with tumor immune infiltration and clinical outcome of ovarian cancer","volume":"39","author":"Zhang","year":"2020","journal-title":"DNA Cell Biol"},{"key":"2025051308483226100_bib80","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.0022-202X.2005.23887.x","article-title":"Molecular cloning and expression of human keratinocyte proline-rich protein (hKPRP), an epidermal marker isolated from calcium-induced differentiating keratinocytes","volume":"125","author":"Lee","year":"2005","journal-title":"J Invest Dermatol"},{"key":"2025051308483226100_bib81","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4103\/aja.aja_20_21","article-title":"Genome-wide association analysis reveals regulation of at-risk loci by DNA methylation in prostate cancer","volume":"23","author":"Liu","year":"2021","journal-title":"Asian J Androl"},{"key":"2025051308483226100_bib82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"2025051308483226100_bib83","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fonc.2013.00292","article-title":"Mitochondrial dysfunction in cancer","volume":"3","author":"Boland","year":"2013","journal-title":"Front Oncol"},{"key":"2025051308483226100_bib84","article-title":"New clarity on the Warburg effect","author":"National Cancer Institute","year":"2022"},{"key":"2025051308483226100_bib85","doi-asserted-by":"crossref","first-page":"e50827","DOI":"10.15252\/embr.202050827","article-title":"OMA1 reprograms metabolism under hypoxia to promote colorectal cancer development","volume":"22","author":"Wu","year":"2021","journal-title":"EMBO Rep"},{"key":"2025051308483226100_bib86","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2025051308483226100_bib87","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.21873\/invivo.12003","article-title":"Implications of low serum albumin as a prognostic factor of long-term outcomes in patients with breast cancer","volume":"34","author":"Fujii","year":"2020","journal-title":"In Vivo"},{"key":"2025051308483226100_bib88","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jpen.1451","article-title":"Hypoalbuminemia: pathogenesis and clinical significance","volume":"43","author":"Soeters","year":"2019","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2025051308483226100_bib89","doi-asserted-by":"crossref","first-page":"7028216","DOI":"10.1155\/2020\/7028216","article-title":"Role of albumin as a nutritional and prognostic marker in elective intestinal surgery","volume":"2020","author":"Galata","year":"2020","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"2025051308483226100_bib90","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.ejon.2005.09.001","article-title":"Cancer-associated malnutrition: an introduction","volume":"9","author":"von Meyenfeldt","year":"2005","journal-title":"Eur J Oncol Nurs"},{"key":"2025051308483226100_bib91","doi-asserted-by":"crossref","first-page":"e00070","DOI":"10.1128\/MCB.00070-18","article-title":"Signaling pathways involved in the regulation of mRNA translation","volume":"38","author":"Roux","year":"2018","journal-title":"Mol Cell Biol"},{"key":"2025051308483226100_bib92","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1742-1241.2007.01668.x","article-title":"NSAIDs and breast cancer: a possible prevention and treatment strategy","volume":"62","author":"Agrawal","year":"2008","journal-title":"Int J Clin Pract"},{"key":"2025051308483226100_bib93","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000452315","article-title":"The role of NSAIDs in breast cancer prevention and relapse: current evidence and future perspectives","volume":"11","author":"Moris","year":"2016","journal-title":"Breast Care (Basel)"},{"key":"2025051308483226100_bib94","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1158\/0008-5472.CAN-12-3232","article-title":"Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures","volume":"72","author":"Kern","year":"2012","journal-title":"Cancer Res"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0287\/3527915\/crc-24-0287.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/1\/138\/3534845\/crc-24-0287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/1\/138\/3534845\/crc-24-0287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T08:48:50Z","timestamp":1747126130000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/1\/138\/751198\/Clinical-Proteomics-Reveals-Vulnerabilities-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0287","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.29050441","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050432","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28263269","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050435","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28263278","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050438","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28263257","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050429","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28263272","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28263251","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28263260","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28263254","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28263266","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28263263","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28263275","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7639466","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}